To evaluate the effect of bombesin (BBS) and neurotensin (NT) on intestinal histopathology, intestinal oxidative stress, and endotoxemia in experimental obstructive jaundice. Summary Background Data: Obstructive jaundice compromises gut barrier function, resulting in endotoxemia. BBS and NT, exerting various biologic actions on gastrointestinal tissues, preserve gut mucosal integrity in cases of injury or atrophy. Methods: Seventy male Wistar rats were randomly divided into 5 groups: I ϭ controls, II ϭ sham operated, III ϭ bile duct ligation (BDL), IV ϭ BDL ϩ BBS (30 g/kg/d), V ϭ BDL ϩ NT (300 g/kg/d). By the end of the experiment, on day 10, endotoxin was measured in portal and aortic blood. Tissue sections of the terminal ileum were examined histologically, and villus density, mucosal thickness, mitotic activity and apoptosis in crypts were assessed. In addition, ileal mucosa was analyzed for DNA and protein content. To estimate intestinal oxidant/antioxidant equilibrium, lipid peroxidation, protein oxidation, and thiol redox state (reduced glutathione ͓GSH͔, oxidized glutathione ͓GSSG͔, total nonprotein mixed disulfides ͓NPSSR͔, protein thiols ͓PSH͔, and protein disulfides ͓PSSP͔) were determined on tissue homogenates from the terminal ileum. Results: BBS or NT administration significantly reduced portal and systemic endotoxemia observed in obstructive jaundice. Both factors reversed obstructive jaundice-induced morphologic features of intestinal atrophy, increasing villus density and mucosal thickness. This effect was accompanied by induction of mitoses and reduction of apoptosis in intestinal crypts. Mucosal DNA and protein content were reduced, although not to significant levels, in BDL animals and restored to control levels after BBS or NT treatment. Moreover, BBS or NT administration protected the intestine in jaundiced rats against oxidative stress, as demonstrated by reduction of intestinal lipid peroxidation, increase of the antioxidant GSH, and decrease of the oxidized forms GSSG and NPSSR, while BBS additionally reduced protein oxidation as well. Conclusions: Administration of BBS or NT in bile duct-ligated rats exerts beneficial effects on intestinal oxidative stress, cell proliferation, apoptosis, and endotoxemia. This observation might be of potential value in patients with extrahepatic cholestasis. (Ann Surg 2005;241: 159 -167) From the
P atients with obstructive jaundice, especially when exposed to the additional stress of an invasive diagnostic or therapeutic procedure, are prone to septic complications and renal dysfunction, contributing to high morbidity and mortality rates. 1 Systemic endotoxemia appears to play a key role in the development of these complications, and a compromised intestinal barrier function permits the escape of endotoxin from the intestinal lumen. 2 Intestinal injury is an important factor implicated in the pathophysiology of gut barrier dysfunction in obstructive jaundice. 2 Previous experimental studies have shown that obstructive jaundice promotes morphologic alterations in the intestinal mucosa indicative of atrophy, increases crypt epithelial apoptosis, and induces intestinal oxidative stress. [3] [4] [5] Bombesin (BBS), a tetradecapeptide originally isolated from the skin of the European frog Bombina bombina, is analogous to gastrin-releasing peptide found to mammalians. 6 BBS stimulates the release of various gut hormones and peptides (eg, gastrin, cholecystokinine, insulin, glucagons, somatostatin, motilin, pancreatic polypeptide, neurotensin) and exerts a trophic effect on intestinal and gastric mucosa and pancreas while it stimulates intestinal motility. 7, 8 It has been previously shown that BBS improves intestinal integrity in experimental models of gut barrier dysfunction, such as after elemental diets, methotrexate administration, chemically induced colitis, and burns. 7,9 -11 Neurotensin (NT), a tridecapeptide originally isolated from the bovine hypothalamus, is additionally found in the gut mucosal endocrine cells (N cells), especially in the ileum. 12 NT stimulates pancreaticobiliary secretions, intestinal blood flow, and colonic motility, while it inhibits small intestinal and gastric motility. It is a potent trophic agent for small and large intestine, gastric mucosa, and pancreas. [13] [14] [15] [16] NT has been shown to prevent intestinal atrophy induced by feeding rats an elemental diet, restores mucosal ulceration after radiation therapy, and enhances intestinal regeneration after small bowel resection. 9, 17, 18 In the present study, we investigated the effect of BBS and NT on small intestinal histopathology and gut barrier function in an experimental model of obstructive jaundice. In addition, we examined the potential effect of these agents on biochemical parameters of oxidant intestinal injury by determining lipid peroxidation, protein oxidation, and thiol redox state.
MATERIALS AND METHODS

Animals
Seventy male albino Wistar rats, weighing 250 to 320 g, were used in the study. They were housed in stainlesssteel cages, 3 rats per cage, under controlled temperature (23°C) and humidity conditions, with 12-hour dark/light cycles, and maintained on standard laboratory diet with tap water ad libitum throughout the experiment, except for an overnight fast before surgery.
The experiments were carried out according to the guidelines set forth by the Ethics Committee of Patras University Hospital, Patras, Greece.
Experimental Design
Animals were randomly divided into 5 groups: I (n ϭ 10): controls, II (n ϭ 15): sham operated, III (n ϭ 15): bile duct ligation (BDL), IV (n ϭ 15): BDL and BBS treatment and V (n ϭ 15): BDL and NT administration. All surgical procedures were performed under strict sterile conditions, using light ether anesthesia. Rats from groups II, III, IV, and V underwent laparotomy on day 0. Via a 1-cm upper midline incision, the gastroduodenal ligament was isolated and the common bile duct was mobilized. In groups III, IV, and V, the common bile duct was further doubly ligated in its middle third with a 4 -0 silk suture and was transected between the 2 ligatures. The abdominal incision was closed in 2 layers with chromic 4 -0 cat gut and 4 -0 silk.
For the 10 subsequent days, the animals of groups IV and V were treated daily with BBS (10 g/kg, subcutaneously, 3 times a day) and NT (300 g/kg, intraperitoneally, once a day) respectively, while the animals of groups I, II, and III were divided to receive daily either 3 subcutaneous or one intraperitoneal injection of 0.5 mL normal saline. All injections were given after topical application of an antiseptic solution of povidone iodine 10%. Previous pilot studies showed that the way of saline administration does not affect the results. On the 10th day, all animals were operated (group I) or reoperated (groups II, III, IV, and V). Samples were obtained according to the experimental protocol, after which the rats were killed by exsanguination.
Peptides Preparation BBS
A stock solution of BBS (Sigma Chemical Co, St. Louis, MO) was prepared by first dissolving the amount of peptide needed for the study in 1 mL sterile water containing 0.1% (wt/vol) bovine serum albumin and then diluted with normal saline containing 1% (wt/vol) bovine serum albumin, so that the amount of BBS needed for each injection to be contained in a volume of 0.1 mL. This solution was divided into equal aliquots of 0.1 mL that were stored in plastic tubes at Ϫ20°C. At the time of administration, to prolong absorption, each aliquot was mixed with 0.4 mL of a solution 8% (wt/vol) hydrolyzed gelatin (Sigma Chemical Co). A final volume of 0.5 mL, containing 10 g BBS/kg body weight, was injected subcutaneously 3 times daily. Selection of dose and route of administration were based on previous reports, in which BBS was demonstrated to exert protective effects against intestinal injury. 7
NT
A stock solution of NT (Sigma Chemical Co) was prepared by first dissolving the amount of peptide needed for the study in 1 mL sterile water containing 0.1% (wt/vol) bovine serum albumin and then diluted with normal saline containing 0.1% (wt/vol) bovine serum albumin, so that the dose of NT needed for each injection to be contained in a volume of 0.1 mL. This solution was divided into equal aliquots of 0.1 mL that were stored in glass vials at Ϫ20°C. At the time of administration, each aliquot was further diluted with 0.4 mL sterile saline to a final volume of 0.5 mL and was given intraperitoneally as a bolus injection containing 300 g NT/kg body weight. Selection of dose and route of administration was based on previous reports in which NT was demonstrated to exert protective effects against intestinal injury. 17
Bilirubin and Endotoxin Measurements
For the determination of total bilirubin, 0.5 mL of blood was collected from all animals by transecting the tip of their tail. Then a laparotomy was performed and in all groups, the portal vein and the abdominal aorta were punctured, and samples of 1 and 2 mL of blood, respectively, were obtained for estimation of endotoxin. Bilirubin concentrations were assayed using a standard biochemical technique and expressed in mg/dL. Endotoxin concentration was determined by the quantitative chromogenic Limulus Amebocyte Lysate test (QCL-1000; BioWhittaker, Walkersville) and expressed in EU/mL. 19 Samples were processed according to the manufacturer's instructions. By this test, it is possible to measure concentrations of endotoxin Ն0.01 EU/mL.
Intestinal Oxidative Stress
A 1-cm-long tissue sample of the terminal ileum of each animal was excised, washed in 9 g/L of NaCL, and was homogenized in a porcelain mortar in liquid nitrogen. Intestinal homogenates were processed for the determination of lipid peroxidation, protein oxidation, thiol redox state(ie, its components reduced glutathione ͓GSH͔, oxidized glutathione ͓GSSG͔, total nonprotein mixed disulfides ͓NPSSR͔, protein thiols ͓PSH͔, and protein disulfides ͓PSSP͔) and total tissue protein as follows.
Lipid Peroxidation
Lipid peroxidation was assayed by a modified (2thiobarbituric acid)-based method as reported previously. 20 Lipid peroxidation was expressed in pmol malondialdehyde (MDA)/mg total protein.
Protein Oxidation
Protein oxidation was assayed by a modified (streptomycin sulfate, 2,4-dinitrophenylhydrazine)-based method. 21 Protein oxidation was expressed in nmol total carbonyl groups/mg total protein.
Thiol Redox State
Thiol redox state components were determined spectrophotometrically using the Elman's reagent (5,5Ј-dithiobisnitrobenzoic acid). 22 The oxidized thiol redox state components were measured after reduction of protein and nonprotein disulfide bridges by sodium borohydride. 22 GSSG was quantified by a standard enzymic assay. 23 Protein in samples was determined as reported previously. 20
Measurements of Mucosal DNA and Protein
DNA and protein content in the terminal ileal mucosa were determined in all animals. A 1 cm long sample of the terminal ileum was excised, opened by longitudinal incision, and washed with cold normal saline. Using a clean glass slide, the mucosa was removed and homogenized in 1 mL NaOH 1 N by means of a polytron homogenizer. The protein was measured according to Lowry's method 24 using a commercial kit (Sigma Diagnostics, Deisenhofen, Germany) and the DNA was determined according to a modified Barton technique. 25
Histologic Evaluation
For histologic examination, tissue samples from the terminal ileum were obtained from all animals. The ileal samples were fixed in 10% neutral buffered formalin, embedded in paraffin, sectioned at 4 m, and stained with hema-toxylin and eosin. In each ileal specimen, several histologic features were evaluated and recorded. These features included architectural distortion, villous blunting, surface and crypt epithelial injury, presence and cell type of inflammation of the lamina propria, surface and cryptal intraepithelial infiltration, lamina propria fibrosis, and granulation tissue formation. The number of villi per centimeter (V/cm) and the total mucosal thickness in micrometers were also assessed. Total mucosal thickness was measured in a minimum of 20 well-preserved villi in each sample. In addition, the number of mitoses and apoptotic cells per crypt were determined in 10 randomly selected samples from each experimental group. Mitoses were counted in all architecturally successive crypts included in the specimen, regardless of crypt orientation, and their total number was divided by the number of the crypts.
Terminal Deoxynucleotidyl Transferase (TdT)-Mediated Deoxyuridine Triphosphate-Biotin Nick-End Labeling (TUNEL) Method
Unstained slides, prepared from the same paraffin blocks, were used for in situ detection of fragmented DNA associated with apoptosis, by applying a standard (TUNEL) assay. For this purpose, the In Situ Cell Death Detection Kit/POD (Roche Diagnostics Corp., Indianapolis, IN) was used according to the manufacturer's instructions. Color was developed with diaminobenzidine (Sigma Fast DAB tablets, D-4293; Sigma, St. Louis, MO), and then sections were counterstained with Harris hematoxylin. For negative control purposes, some slides were incubated with label solution not containing TdT. To avoid an overestimation of the TUNELpositive cells, only the cells that exhibited both morphologic features of apoptosis on light microscope, not associated with inflammation, and positive TUNEL staining for fragmented DNA were considered as positive. Detection of apoptotic cells performed manually at a ϫ400 magnification on an Olympus BX 40 light microscope. The presence of apoptotic cells was counted in all architecturally successive crypts included in the specimen, regardless of crypt orientation, and their total number was divided by the number of the crypts.
Histopathologic parameters were evaluated by 2 of the authors (SFA and CDS) independently and scored in a blind fashion without knowledge of the experimental group from which the specimens were derived.
Statistical Analysis
The results are expressed as mean (SD). Comparisons among multiple groups were performed using the one-way ANOVA, followed by Bonferroni's post hoc test when variances across groups were equal or by Dunnett's T3 post hoc test when variances were not equal. Variance equality was tested by Levene statistical analysis. Differences were considered significant when P Ͻ 0.05.
RESULTS
Animal Outcomes
All animals survived and were in good health throughout the experiment. Bile duct-ligated rats were clinically jaundiced within 3 days. At reoperation on day 10, it was found that the ligation and division of the common bile duct in groups III, IV, and V had been successful in all cases and resulted in dilatation of the common bile duct remnant proximal to the ligature without signs of bile leakage.
Bilirubin and Endotoxin Concentrations
BDL led to significantly raised total bilirubin levels in groups III, IV, and V compared with control and sham groups (P Ͻ 0.001). Figure 1 demonstrates endotoxin values, measured in blood collected from portal vein and aorta. Jaundiced animals (group III) presented significantly elevated endotoxin concentrations in portal and aortic blood compared with groups I and II (P Ͻ 0.001). When ligation of common bile duct was followed by either BBS or NT treatment, endotoxin values were significantly reduced both in portal vein (P Ͻ 0.001, respectively) and aorta (P Ͻ 0.001 and P Ͻ 0.01, respectively).
Intestinal Oxidative Stress
Lipid peroxidation was increased in the intestine of jaundiced animals (P Ͻ 0.01 versus sham operated), while BBS or NT administration significantly reduced it (P Ͻ 0.01 and P Ͻ 0.001, respectively) ( Fig. 2A) .
Protein oxidation was also increased in group III (P Ͻ 0.001 versus group II) and reduced in BBS-treated animals (group IV) (P Ͻ 0.001), while NT administration (group V) had no effect (Fig. 2B ).
Thiol redox state in group III showed a significant increase of NPSSR, GSSG, and PSSP (P Ͻ 0.001 versus group II, respectively), while GSH was significantly de-creased (P Ͻ 0.001, compared with group II). After BBS or NT administration, NPSSR and GSSG were both significantly reduced (P Ͻ 0.001, respectively), and GSH was increased to almost control levels (P Ͻ 0.001) ( Table 1) .
Mucosal DNA and Protein
DNA and protein content of the intestinal mucosa were decreased in BDL rats, while in BBS-or NT-treated animals, values were increased to normal levels or slightly above, though differences between experimental groups were not statistically significant ( Table 2) .
Intestinal Morphology
Overall, the ileal architecture remained intact and epithelial continuity was retained in all specimens studied. The ileal biopsies from the BDL group demonstrated a significant reduction in the number of villi per centimeter and in total mucosal thickness (P Ͻ 0.001 versus groups I and II) ( Table  2) . After BBS administration, both morphometric parameters were increased beyond control levels (P Ͻ 0.001, versus groups I, II, and III). Likewise, NT treatment led to significantly increased villus density (P Ͻ 0.001 versus groups I, II, and III) and mucosal thickness (P Ͻ 0.001 versus group III). Intestinal crypt mitotic activity was reduced in jaundiced rats (P Ͻ 0.05 versus sham-operated and P Ͻ 0.001 versus controls), while after BBS or NT treatment it was significantly increased (P Ͻ 0.001, compared with group III, respectively) (Fig. 3A) . Crypt epithelial apoptosis was present in all intestinal samples evaluated. The ratio of apoptotic cells per crypt in ileal specimens from control and sham-operated groups was significantly lower compared with group III (P Ͻ 0.01 and P Ͻ 0.05, respectively). After BBS or NT administration, crypt epithelial cell apoptosis was significantly reduced (P Ͻ 0.01, compared with BDL, respectively) ( Fig. 3B ). 
DISCUSSION
An intact intestinal barrier function effectively separates potentially harmful intraluminal elements such as bacteria and endotoxins from extraintestinal tissues and the systemic circulation. Obstructive jaundice has been shown to compromise the anatomic and functional integrity of the intestinal barrier, resulting in the translocation of indigenous bacteria and endotoxins to remote organs and tissues. 4, 26 The excessive presence of endotoxins in portal and systemic circulation stimulates a systemic inflammatory response, characterized by the release of cytokines and other proinflammatory mediators (eg, interleukin-1, interleukin-6, tumor necrosis factor-␣, interferon-␥, platelet activating factor, nitric oxide, prostaglandins, and oxygen free radicals). These substances may produce structural and functional deleterious effects on remote organs, especially on the kidneys, lungs, and heart, resulting in multiple organ dysfunction syndrome. 27 To the best of our knowledge, the results of the present study demonstrate for the first time that administration of BBS or NT improves intestinal barrier function in experimental obstructive jaundice, leading to significantly lower portal and systemic endotoxin concentrations. Treatment with these factors reversed intestinal atrophy, as evidenced by increased villus density and mucosal thickness and preservation of mucosal DNA and protein content to control levels. This effect was accompanied by induction of cell proliferation and inhibition of programmed cell death in intestinal crypts. Moreover, they protected the intestinal tissue from oxidant injury, reducing the reactive oxygen species (ROS)-induced modification of cellular lipids and proteins and restoring thiol redox state. The promotion of crypt cell proliferation after BBS or NT treatment may be a direct receptor-mediated or an indirect effect. Although BBS receptors were not detected in the normal epithelium of the small intestine in the man, 28 there is evidence from animal studies that ileal and jejunum epithelial cells present BBS receptors, 29, 30 while NT receptors have also been detected in intestinal epithelial cells. 31 BBS and NT are potent cellular growth factors whose binding to their receptors activates a mitogenic signal to the nucleus. 32 An indirect mechanism may be related to the reduction of intestinal oxidative stress after BBS or NT treatment. It has been shown that exposure of intestinal epithelium in subtoxic oxidative stress suppresses mucosal cell proliferation and turnover, and this effect is reversed after restoration of the glutathione redox state, which is in agreement with our results. 33 ROS may function as intracellular messengers involved in the modulation of diverse cellular processes, including proliferation, differentiation, stress responses, and cell death. Recent experimental data suggest that ROS promote cell growth arrest via a mitogen-activated protein kinase-dependent pathway that alters the status of growth regulatory proteins, and treatment with antioxidant enzymes prevents this effect. 34 Cell death by apoptosis plays a crucial role in regulation of intestinal epithelial homeostasis. 35 Definite evidence of apoptosis is seen in the crypt, where apoptotic cells are seen once in every 5th to 10th crypt section. 35 Control animals presented this basal level of apoptotic activity known as spontaneous apoptosis, which serves to remove either occasional overproduced stem cells or stem cells with minor DNA damage caused by external factors. Obstructive jaundice resulted in a significant increase of apoptosis in the crypt, while BBS and NT reduced the rate of apoptotic death to control levels. Potential mechanisms for increased crypt epithelial apoptosis after BDL may implicate the excessive release of proinflammatory cytokines such as tumor necrosis factor, interleukin-1, and interleukin-6, activation of cytotoxic T lymphocytes that act through either granzyme B or Fas receptor pathways, or a direct action of bacterial toxins. 35, 36 The antiapoptotic effect of BBS and NT may be mediated by acting to 1 or more of the above factors, but any conclusion on this subject is premature. However, since moderate noncytotoxic oxidative radical stress is an important inducer of apoptosis via a cytochrome c-mediated activation of the caspase family, 37 we are tempted to speculate that the antiapoptotic effect of BBS and NT in the intestine of jaundiced rats is mediated, at least partly, by their antioxidant action.
It is of interest that BBS and NT effectively reduced intestinal oxidative stress in jaundiced rats. Previous experimental studies had shown that BBS or NT improved gut barrier function after methotrexate treatment, chemically induced colitis, radiation therapy, or burns. 7, 10, 11, 17 These models of gut barrier dysfunction are associated with the presence of intestinal oxidative stress; 38 -40 however, the effect of BBS and NT on biochemical parameters of oxidant tissue injury is not adequately elucidated. Free radical-mediated reactions are responsible for the formation of aldehydic lipid hydroperoxide decomposition products like MDA (lipid peroxidation) and carbonyls in cellular proteins (protein oxidation). 41, 21 Administration of BBS or NT significantly reduced intestinal MDA content in jaundiced rats, while BBS exerted an additional beneficial effect by reducing protein oxidation as well. Thiol redox state is another indicator of the intracellular oxidant/antioxidant equilibrium. 42 Under oxidative conditions, non-protein thiols (RSH, and especially GSH) and PSH can be converted to oxidized disulfides GSSG, NPSSR, and PSSP. 22, 42, 43 Specifically, glutathione is the major regulator BBS and NT in Obstructive Jaundice of the intracellular redox state and participates in redox reactions via the reversible oxidation of its active thiol. 42 Both BBS and NT increased GSH, which is the main intracellular antioxidant, and reduced the oxidized forms GSSG and NPSSR. These alterations on thiol redox state are indicative of a protective effect of these peptides against intestinal oxidative stress in obstructive jaundice. Though great progress has been made in understanding the signal transduction pathways activated by engagement of BBS and NT to their receptors, to our knowledge, there is no study focused on their interrelation with the intracellular redox state, and only speculations on the potential mechanism(s) may be offered. Both peptides exert their effects by binding to specific G-protein coupled receptors on the surface of the target cell, 32, 44 followed by activation of protein kinase C (PKC), which plays a central role in transducing neuropeptides' signals. 32 Recent studies have shown that increased cellular PKC activity promotes the mitochondrial translocation and organization in a catalytically active form of a representative isoform of glutathione S-transferases, which are an important antioxidant enzyme system. 45 Since structural and functional integrity of mitochondria is crucial for the maintenance of cell metabolic homeostasis, this mechanism enhances cellular defense against oxidant injury.
Alternatively, BBS and NT may have exerted their antioxidant effect via reduction of systemic endotoxemia, which is associated with generation of oxygen free radicals via numerous mechanisms. A xanthine oxidase-dependent pathway mediates endotoxin's pro-oxidant action in the intestinal tissue. 2, 46 Increased conversion of the enzyme xanthine dehydrogenase to xanthine oxidase has been previously described in the intestine of jaundiced rats. 47 Under systemic endotoxemia, intestinal hypoxanthine is markedly increased in experimental animals, especially in the ileum, thus providing an important substrate for ROS formation by xanthine oxidase. 46 Moreover, endotoxin up-regulates inducible nitric oxide synthase expression and enzymatic activity in the intestine, promoting overproduction of nitric oxide. 48 Under the conditions of mucosal acidosis that are present in the intestine of endotoxemic rats, nitric oxide may lead to the formation of peroxynitrous acid that is considered as a strong oxidizing agent. 48 Furthermore, endotoxin reduces splanchnic blood flow and disrupts intestinal microcirculation. 49 NT and BBS apart from endotoxin restriction within the gut lumen increase intestinal blood flow and improve villi microcirculation, 50,51 preventing hypoxia and enterocyte ATP depletion that leads to oxidative damage.
In conclusion, the present study demonstrates that the gut trophic peptides BBS and NT improve intestinal barrier function and reduce endotoxemia in experimental obstructive jaundice. This effect is, at least in part, related to a regulatory effect of the peptides on epithelial cell production and death in the crypt and reduction of intestinal oxidative stress.
Although the results of laboratory experiments are not readily applicable to the clinical situation, we feel that BBS and NT merit consideration as potential therapeutic agents for the improvement of gut barrier function in patients with extrahepatic cholestasis.
